Tayca Corporation Overview
| Item | Detail |
|---|---|
| Legal name | テイカ株式会社 / TAYCA CORPORATION |
| Former names | 帝国人造肥料株式会社 (Teikoku Jinzo Hiryo, 1919–1942); 帝国化工株式会社 (Teikoku Kako, 1942–1989) |
| Founded | December 1919 (incorporated to manufacture superphosphate fertiliser) |
| Incorporation jurisdiction | Japan (Companies Act); governance form: company with an Audit and Supervisory Committee |
| Registered head office | 1-3-47 Funamachi, Taisho-ku, Osaka 551-0022 (site of the Osaka Plant) |
| Corporate / IR office | 4-11-6 Tanimachi, Chuo-ku, Osaka (per Shared Research company profile) |
| Tokyo branch | Shin-Nihon Building 4F, 3-8-2 Nihonbashi, Chuo-ku, Tokyo |
| Exchange and ticker | Tokyo Stock Exchange Prime Market, securities code 4027 (listed May 1949; Prime since 4 April 2022) |
| ISIN / CUSIP | no CUSIP for a TSE-only listing) — confirm with JPX |
| Fiscal year end | 31 March |
| Employees (consolidated) | 862 (31 March 2026); parent company 577 |
| Auditor | Seiryo Audit Corporation (清稜監査法人); continuous audit period 3 years; audit fee JPY 30M (FY3/2026) |
| Shares issued | 22,914,414 (after cancellation of 1,000,000 treasury shares on 27 May 2026) |
| Treasury shares | 252,831 (30 June 2026) |
| Share price | JPY 2,311 (close, 7 October 2026) |
| Market capitalisation | ≈JPY 52.4bn (22.66M shares outstanding ex-treasury at 30 June 2026 × JPY 2,311) |
| Website | https://www.tayca.co.jp/ |
| Consolidated subsidiaries | 8 at 31 March 2026 (7 after the absorption of TFT Co., Ltd. on 1 April 2026) |
The entity profiled is TAYCA CORPORATION (テイカ株式会社), Osaka, Japan, a listed company on the Prime Market of the Tokyo Stock Exchange. The "Public company" classification in the input list is correct.
| Metric | FY3/2026 |
|---|---|
| Consolidated employees | 862 |
| of which Functional Materials | 331 |
| of which Electronic Materials & Chemicals | 349 |
| of which Other | 112 |
| of which Corporate | 70 |
| Parent employees | 577 |
| Parent average age (years) | 40.5 |
| Parent average tenure (years) | 17.0 |
| Parent average salary (JPY thousand) | 6,674 |
Source: FY3/2026 Yuho.
Tayca is a 107-year-old Osaka specialty-inorganic and fine-chemicals manufacturer that has evolved from a sulphuric-acid and fertiliser maker into a niche materials supplier built on three core technologies: inorganic/organic synthesis, particle surface treatment, and dispersion/stabilisation. Its legacy anchor is sulphate-process titanium dioxide pigment from the Okayama Plant, a commoditising business now under severe pressure from Chinese imports that forced a JPY 3.17bn impairment in FY3/2026. Around that core, Tayca built globally relevant niches: ultrafine titanium dioxide and zinc oxide used as mineral UV filters in sunscreens, oxidant/dopant chemistries for conductive-polymer capacitors used in vehicles and AI servers, linear alkylbenzene sulphonate surfactants produced in Japan, Thailand and Vietnam, and piezoelectric ceramics and single crystals for medical ultrasound via US subsidiary TRS Technologies. The May 2026 "MOVING-10 STAGE3" plan pivots capital toward electronics and medical piezo, restructures titanium dioxide, and commits at least JPY 20bn to shareholder returns.
The company's own description
In its FY3/2026 Annual Securities Report, Tayca describes the group as the parent plus eight consolidated subsidiaries whose principal business is the manufacture and sale of chemical industrial products and piezoelectric materials, plus the transport and storage of chemicals. Its corporate philosophy is to use the power of chemistry to create "sources of inspiration" and deliver dreams and smiles worldwide; the operating slogan in recruitment and IR materials is "まじめに感動素材" (earnestly creating inspiring materials). The company's statement of its value-creation logic, in the section on its basic policy on corporate control, traces a lineage from sulphuric-acid technology to titanium dioxide and surfactants, and from accumulated surface-treatment, dispersion and sulphonation know-how to high-value products such as cosmetic-grade ultrafine titanium oxide, surface-treated products and conductive-polymer agents for high-performance capacitors.
Independent characterisation
Tayca is best understood as a two-speed materials company. Roughly half of revenue (Functional Materials, JPY 26.2bn in FY3/2026) is titanium-dioxide-based: a commodity pigment line facing structural decline in Japan and price competition from Chinese sulphate- and chloride-route producers, and a higher-value cosmetic ultrafine-particle line exposed to inventory cycles at global sunscreen formulators. The other half (Electronic Materials & Chemicals, JPY 30.0bn in FY3/2026 on the old segment definition) combines a stable, low-growth ASEAN surfactant franchise with two genuinely growing technology niches: conductive-polymer capacitor chemicals and piezoelectric materials. The investment case therefore turns on whether the growth niches can scale fast enough, and whether management can stop the titanium-dioxide franchise from destroying value, while the balance sheet (68.9% equity ratio, JPY 17.6bn of investment securities) is recycled into returns.
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | Almost entirely product sales of manufactured chemicals and materials; minor service revenue from warehousing, logistics and plant engineering (Other segment, JPY 1.15bn external sales in FY3/2026). No subscription or licensing revenue is disclosed. |
| Production model | Make-to-stock; the company states it does not engage in build-to-order production (FY3/2026 Yuho). |
| Value-chain position | Mid-stream intermediate/ingredient supplier. Buys ilmenite/titanium ore (imported), sulphur/sulphuric acid inputs, petrochemical alkylbenzene and specialty monomers; sells to paint, ink, plastics, cosmetics, detergent, capacitor and ultrasound-probe manufacturers. |
| Customer types | Paint makers (e.g., Kansai Paint, Dainichiseika, Dai Nippon Toryo, Asahipen, Kikusui Chemical — all disclosed as customers in the cross-shareholding register), global cosmetic/sunscreen formulators and OEMs, household-detergent and hair-care producers, chemical companies (NOF, Toho Chemical, Daiichi Kogyo Seiyaku, Sugai Chemical, Niitaka), capacitor manufacturers, medical ultrasound OEMs, and trading houses (Mitsubishi Corp., Mitsui & Co., Sumitomo Corp., Sojitz). |
| End-markets | Architectural and industrial coatings, printing inks, plastics, paper; sunscreens and colour cosmetics; household detergents and personal care; automotive electronics, AI servers, telecom base stations, PCs/smartphones; medical diagnostic ultrasound; industrial sensors. |
| Purchased goods | JPY 1.63bn of merchandise purchased for resale in FY3/2026 (2.8% of sales), indicating a predominantly manufacturing model. |
Production and sales by segment (FY3/2026, old segment basis)
| Metric (JPY Mn) | Functional Materials | Electronic Materials & Chemicals | Other | Total |
|---|---|---|---|---|
| Production value (at selling prices) | 25,759 | 29,449 | 0 | 55,208 |
| YoY production change (%) | -15.3 | 17.6 | 0 | -0.5 |
| Merchandise purchases | 312 | 1,316 | 0 | 1,629 |
| Sales | 26,213 | 30,007 | 1,152 | 57,373 |
| YoY sales change (%) | -8.0 | 14.9 | 3.0 | 2.9 |
Source: FY3/2026 Yuho, Section "Production, Orders and Sales".
Strategy
Long-term vision "MOVING-10" (FY3/2021–FY3/2030)
Four basic policies (company): shift management resources to strong growth businesses; transform business structure in response to environmental change; create global-niche-top products; leverage group synergies. The original FY3/2030 aspiration of an operating margin of 15% or more and ROE of 12% or more (cited in the FY3/2025 Tanshin) has been replaced by STAGE3 targets of ROE of 8% or more and operating profit of JPY 4.5bn.
From STAGE2 to STAGE3
| Item | STAGE2 (May 2024) target for FY3/2027 | FY3/2026 actual | STAGE3 (May 2026) target for FY3/2030 |
|---|---|---|---|
| Net sales (JPY 100M) | 680 | 574 | 590 |
| Operating profit (JPY 100M) | 60 | 22 | 45 |
| Operating margin (%) | 9 | 4 | 8 |
| ROE (%) | 7 | -1 | 8 |
| EBITDA (JPY 100M) | 105 | 61 | 73 |
STAGE2 was terminated a year early. Management's own scorecard (STAGE3 plan, p.3) concluded that margin recovery failed (4% versus a 6% interim plan), selection and concentration remained incomplete because of Functional Materials weakness, new businesses struggled to commercialise, ROE stayed low and capital policy/IR were "still under consideration"; successes were a more-than-fourfold increase in conductive-polymer capacity versus FY3/2024 and an engagement score improvement.
STAGE3 framework
| Pillar | Initiative | Quantified target (FY3/2027–FY3/2030 unless stated) |
|---|---|---|
| Electronic materials | Conductive-polymer capacity completion (FY3/2027), next-generation capacitor technology, titania sol commercialisation, next-generation semiconductor/AI-infrastructure materials | Electronic-materials sales ≥2× FY3/2026 by FY3/2030 (130%+ in FY3/2027) |
| Medical & piezoelectric | Japan–US dual manufacturing; single-crystal and ceramic technology upgrades; new uses and downstream entry | Segment sales ≥JPY 6bn by FY3/2030; R&D JPY 3bn; capex ≥JPY 2bn; mass production from FY3/2029; segment OCF from JPY 0.8bn to 1.5bn |
| New business | Robotics, XR and bio; stage-gate governance; open innovation, VC, M&A, JV | Sales ≥JPY 1bn by FY3/2030; investment envelope ≥JPY 5bn |
| Functional materials reform | Cosmetics: overseas expansion to emerging brands and OEMs in Asia and South America, new high-value products, cost compression. Pigment TiO2: fixed/variable cost compression, pruning low-margin grades, price revisions, focus on key domestic customers | Segment operating profit from −JPY 0.6bn to +JPY 0.4bn; segment OCF ≈JPY 1.8–2.0bn p.a. |
| Capital allocation | Cash in: OCF ≥JPY 27bn plus JPY 24bn from debt and cross-shareholding reduction | Growth capex ≥JPY 15bn (medical/electronics JPY 10bn, new business ≥JPY 5bn); maintenance JPY 16bn (equipment JPY 14bn, systems JPY 2bn); shareholder returns ≥JPY 20bn |
| Shareholder returns | Dividend: higher of DOE 3% or 100% payout; buybacks | Buybacks ≥JPY 10bn; early achievement of P/B ≥1.0x |
| Balance-sheet management | Inventory-days reduction; receivable/payable terms; reduce policy shareholdings; use leverage | Inventory turnover shortened by 1 month |
| Systems | Cost/budget/purchasing system renewal (FY3/2029), sales-logistics system renewal (FY3/2030) | JPY 2bn system investment |
| Human capital | Career development, talent management, training rebuild | Engagement score 65 → 71 |
| Environment | SBT certification; Scope 1–3 reduction; external ratings | Scope 1+2 −42% and Scope 3 −25% by FY3/2031 vs FY3/2025 base; CDP climate A− and EcoVadis ≥70 by FY3/2030 |
Basic policies: (1) Business strategy — expand operating profit and realise new businesses; (2) Capital policy — capital efficiency and more aggressive business investment; (3) Strengthening the management foundation.
Near-term guidance
| Guidance (JPY Mn) | H1 FY3/2027 (revised 7 Aug 2026) | FY3/2027 (13 May 2026, unchanged) |
|---|---|---|
| Net sales | 29,500 | 59,500 |
| Operating profit | 1,800 | 2,500 |
| Ordinary profit | 2,100 | 2,900 |
| Net income | 1,400 | 1,800 |
| EPS (JPY) | 61.32 | 78.84 |
| DPS (JPY) | 40 | 80 |
The FY3/2027 guidance excludes any effect from Middle East tensions, which management said could not be reasonably estimated (FY3/2026 Yuho). Q1 operating profit of JPY 1.31bn already equals 52% of the full-year target, and the H1 guide was raised, while the full-year guide was left unchanged — a conservative stance.
Products & Services
Tayca does not publish price lists; pricing is negotiated B2B on a per-tonne or per-kilogram basis, and the company refers to periodic "price revisions" in its disclosures.
Functional Materials
| Product line | Description and capabilities | Target customers | Status / dates | Notes |
|---|---|---|---|---|
| Pigment titanium dioxide (rutile and anatase; marketed under the TITANIX brand) | Sulphate-process TiO2 white pigment produced at Okayama since 1951; grades tailored for paints, inks, plastics, paper | Domestic architectural/industrial paint makers, ink and plastics compounders | Mature; JPY 3.17bn impairment of related fixed assets in FY3/2026 | Company states volumes and sales fell in FY3/2026; partial price increases implemented; strategy is to focus on applications where Tayca grades are indispensable |
| Ultrafine titanium dioxide (MT-series) | Rutile microparticle TiO2 with UV-scattering/absorbing function; particle-size and surface-treatment control for transparency, spreadability, water resistance | Global sunscreen and cosmetic formulators and OEMs | Developed from the 1990s; continuously upgraded | Company and integrated-report summaries claim a global top position in sunscreen applications (company claim) |
| Ultrafine zinc oxide (MZ-series) | Microparticle ZnO UV-A/UV-B filter | Sunscreen formulators | An "ultra-high-transparency" ultrafine ZnO was launched in FY3/2025 and is produced under GMP, with strong traction in the US (FY3/2026 Yuho) | Benefits from the shift to mineral UV filters |
| Surface-treated products (cosmetic pigments) | Organically/inorganically surface-modified powders, including O/W-sunscreen-compatible grades | Colour-cosmetics and skincare formulators | Production since January 1996; Kumayama Plant built 2006 | Overseas customer destocking depressed FY3/2025–FY3/2026 sales |
| Spherical silica texture modifier | Microplastic-bead replacement with proprietary surface treatment giving a soft feel; a TiO2-encapsulated variant boosts SPF | Cosmetics formulators | Launched recently (FY3/2026 Yuho) | Regulatory tailwind from microplastics restrictions |
| Titania sol (ultra-high refractive index) | Nano-dispersed TiO2 sol for optical films combining high refractive index and transparency | Display and optical-component makers | Adopted in optical members of the latest automotive displays (FY3/2026 Yuho); mass-production study under way; targeted at AR/VR devices | Named STAGE3 "high value-added" growth theme |
| Photocatalyst and environmental-catalyst TiO2 | Ultrafine TiO2 for antifouling, deodorising and exhaust-gas reduction | Building-materials and environmental-equipment makers | Established | — |
| Toner external additives and organic-inorganic composite powders | Surface-modified microparticles for toner flow, functional coatings, optical and electronic components | Toner and coatings makers | Established/development | — |
| Biomass titanium oxide | TiO2 coated with silica extracted from rice husks to raise biomass content of packaging inks | Packaging-ink makers | Development/early commercial (FY3/2026 Yuho) | Sustainability-linked product |
| Sericite (via Japan Sericite Co.) | Mica-group mineral used in cosmetics; JV procures raw material for Tayca | Cosmetics | JV established April 2017 | 50% owned, consolidated on control basis |
Electronic Materials & Chemicals
| Product line | Description and capabilities | Target customers | Status / dates | Notes |
|---|---|---|---|---|
| Conductive-polymer agents (導電性高分子薬剤) | Oxidant/dopant and related formulations used to form the solid electrolyte of conductive-polymer capacitors, improving reliability and electrical characteristics | Capacitor manufacturers serving automotive electronics (EV, ADAS), AI servers, base stations, PCs | Strong growth in FY3/2025–Q1 FY3/2027; JPY 1.5bn Osaka capacity expansion (start Dec 2024, completion Mar 2027); capacity raised to more than 4× the FY3/2024 level per STAGE2 review | STAGE3 targets electronic-materials sales of at least 2× FY3/2026 by FY3/2030; next-generation capacitor development under way |
| Surfactants (marketed under the TAYCAPOWER brand among others) | Linear alkylbenzene sulphonic acid/sulphonates, solubilisers, industrial emulsifiers, acid-curing catalysts | Household-detergent, shampoo and hair-care makers; industrial users | Production at Osaka since 1961, Thailand since 2001, Vietnam since 2014 | Stable volume growth in FY3/2026 (detergents, hair care); ASEAN expansion is a stated priority |
| Sulphuric acid | Contact-process and refined sulphuric acid | Chemical industry; internal use | Since 1938/1964 | Integrated with TiO2 sulphate process |
| Non-toxic anti-corrosive pigments (K-WHITE series) | Heavy-metal-free (e.g., phosphate-based) rust-prevention pigments | Automotive and industrial coatings | Phosphate production since 1981 | Export weakness in FY3/2024–FY3/2025 |
Medical & Piezoelectric
| Product line | Description and capabilities | Target customers | Status / dates | Notes |
|---|---|---|---|---|
| Piezoelectric ceramics (Japan) | Lead-zirconate-titanate-type ceramics and processed elements for transducers | Medical ultrasound probe makers; industrial sensor makers | Long-established | Horizontal deployment of ceramic and processing technology into non-healthcare sensors |
| Piezoelectric single crystals and devices (TRS Technologies, USA) | Relaxor single-crystal materials and components with high electromechanical coupling for high-performance ultrasound | Global ultrasound OEMs; defence and industrial sensing | Acquired January 2018 | Dual Japan–US manufacturing base; STAGE3 earmarks JPY 3bn of R&D and at least JPY 2bn of capex (FY3/2027–FY3/2030), with mass production of next-generation products from FY3/2029 (company "FY2028") |
New business development themes
| Theme | Description | Status |
|---|---|---|
| Semiconductor encapsulant and polishing materials | Materials for AI-era semiconductors | R&D (FY3/2026 Yuho) |
| Next-generation hazardous-substance adsorbents | Leveraging TiO2 shape and particle-size control | R&D |
| Robotics, XR, bio | STAGE3 target fields for new business | Stage-gate process; ≥JPY 5bn investment envelope including M&A, JV and VC |
Other (services)
| Service | Provider | Description |
|---|---|---|
| Warehousing and transport | Tayca Warehouse Co. (Osaka, Nishiyodogawa) | Storage and logistics for Tayca products and third parties |
| Plant engineering and cargo handling | Tayca M&M Co. | Engineering for Tayca plants and handling services |
Financial Narrative
All figures JPY M unless stated; FY3/2022 to FY3/2026. Sources: Kessan Tanshin FY3/2024 and FY3/2025, FY3/2026 Yuho, Yuho multi-year summaries; FY3/2022 items and cash-flow detail cross-checked against S&P Global Market Intelligence data (via StockAnalysis). Ratios are analyst calculations unless marked "company".
Income statement
No dilutive securities exist (company), so diluted EPS equals basic EPS. Company-stated EBITDA in the STAGE3 plan: JPY 6.7bn (FY3/2025) and JPY 6.1bn (FY3/2026), consistent with the calculation above. FY3/2021 revenue was JPY 38,402M (Yuho), used for the five-year CAGR.
Revenue CAGR: 8.4% p.a. over five years (FY3/2021 JPY 38.4bn to FY3/2026 JPY 57.4bn); 5.5% p.a. over four years from FY3/2022. Note that FY3/2021 was a COVID trough (−15.5% YoY), flattering the five-year rate.
Special items: FY3/2026 included a JPY 3,170M impairment loss (general-purpose TiO2 assets) and a deferred-tax benefit of JPY 790M. FY3/2023 and FY3/2024 included fixed-asset disposal losses of JPY 549M and 189M; FY3/2024–FY3/2025 included offsetting government subsidies and asset-compression losses (JPY 184M and 213M).
Commentary. The P&L shows a business that grew top-line through pass-through pricing (FY3/2022–FY3/2023) but has not converted it to profit. Gross margin compressed by 5.1 percentage points between FY3/2022 and FY3/2026 because raw material and fuel costs stayed high, titanium-dioxide volumes fell, and depreciation stepped up on new functional-particle capacity (D&A rose 23% in FY3/2026). Operating profit has oscillated between JPY 2.2bn and JPY 4.2bn, with the troughs (FY3/2024, FY3/2026) driven by different businesses: in FY3/2024 conductive polymers and surfactants slumped while cosmetics recovered; in FY3/2026 the reverse occurred. This negative correlation between segments has reduced volatility but also capped upside. Quarterly operating profit in FY3/2026 was JPY 957M, 450M, 48M and 721M — the near-zero Q3 triggered the February 2026 forecast cut and plan review.
Balance sheet
FY3/2022 total debt is derived from the S&P-reported net cash of JPY 8,055M; its short/long split and FY3/2022 current liabilities were not available. FY3/2026 BPS is calculated as JPY 60,972M equity / 22.83M shares. FY3/2026 short-term debt is the balance-sheet "short-term borrowings" line (JPY 6,568M), which on Tayca's presentation appears to include the current portion of long-term debt (analyst inference from the FY3/2026 cash-flow movements). Lender exposure disclosed in the cross-shareholding note: Mizuho group JPY 6,005M, MUFG group JPY 3,506M, Tomato Bank JPY 946M (31 March 2026).
Commentary. The balance sheet remains conservatively capitalised but is no longer net cash: three years of capex above operating cash flow, funded by JPY 15.7bn of new long-term borrowing (FY3/2023–FY3/2026), moved the group from JPY 8.1bn net cash to JPY 1.1bn net debt. Equity rose despite the FY3/2026 loss because unrealised gains on cross-shareholdings jumped JPY 3.7bn (Mitsubishi Corp. shares alone rose from JPY 3.2bn to JPY 6.5bn). The STAGE3 plan itself labels the equity ratio as excessive and identifies policy shareholdings, inventories and receivables as over-allocated capital.
Cash flow
Capex on an accrual (investment-decision) basis was JPY 4,721M in FY3/2026: Functional Materials 3,211, Electronic Materials & Chemicals 1,038, Other 164, corporate IT 307 (FY3/2026 Yuho).
Commentary. Cumulative five-year free cash flow was negative (−JPY 1.8bn) against cumulative dividends and buybacks of JPY 4.8bn — the gap was debt-funded. The FY3/2023 collapse in OCF reflected a JPY 4.7bn inventory build during the post-COVID supply squeeze. The FY3/2025–FY3/2026 capex peak (JPY 13.0bn over two years, more than twice depreciation) was concentrated in Functional Materials (new functional-particle plant, land of JPY 2.7bn acquired in FY3/2025) — capacity whose returns have so far disappointed, as demonstrated by the FY3/2026 profit decline in that segment.
Ratios
Third-party ROIC for FY3/2026 is 3.4–3.5% (S&P/StockAnalysis, EDINET DB) on different definitions. The company's STAGE3 plan cites an ROE series of 4% (FY3/2021), 6%, 6%, 3%, 4% and −1% (FY3/2026), consistent with the table.
Commentary. Returns are structurally below the cost of equity (S&P estimates WACC at 5.6%; Japanese specialty-chemicals investors typically assume a cost of equity of 7–8%). The cash conversion cycle of around 200 days is exceptionally long — roughly seven months of sales tied up in receivables and inventory — and the company targets a one-month reduction in inventory days plus renegotiation of collection terms. Each 30-day cut in DIO frees approximately JPY 4bn of cash at FY3/2026 cost levels (analyst estimate: JPY 48.4bn COGS / 365 × 30).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment (From Q1 FY3/2027) Overview
| Segment (from Q1 FY3/2027) | Contents |
|---|---|
Functional Materials (機能性材料事業) | Pigment-grade titanium dioxide; ultrafine titanium dioxide; ultrafine zinc oxide; surface-treated products (cosmetics), titania sol, photocatalyst and toner-additive grades |
Electronic Materials & Chemicals (電子材料・化成品事業) | Conductive-polymer agents for capacitors; surfactants (Japan, Thailand, Vietnam); sulphuric acid; non-toxic anti-corrosive pigments |
Medical & Piezoelectric (医療・圧電関連事業) — new | Piezoelectric ceramics and single crystals (Japan and TRS Technologies, USA) |
Other | Warehousing, transport, plant engineering and cargo handling (Tayca Warehouse, Tayca M&M) |
Segment sales (JPY Mn)
| Segment sales (JPY Mn) | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|
Functional Materials | 27,130 | 28,074 | 28,495 | 26,213 |
Electronic Materials & Chemicals (incl. piezo) | 26,286 | 23,663 | 26,123 | 30,007 |
Other (external sales) | 1,355 | 1,255 | 1,118 | 1,152 |
Consolidated total | 54,773 | 52,993 | 55,737 | 57,373 |
Segment profit (JPY Mn)
| Segment profit (JPY Mn) | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|
Functional Materials | 2,221 | 562 | 1,461 | -600 |
Electronic Materials & Chemicals (incl. piezo) | 1,686 | 1,461 | 1,784 | 2,500 |
Other | 321 | 327 | 334 | 300 |
Adjustments | -5 | -26 | -55 | -24 |
Consolidated operating profit | 4,224 | 2,325 | 3,525 | 2,176 |
Segment operating margin (%)
| Segment operating margin (%) | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|
Functional Materials | 8.2 | 2.0 | 5.1 | -2.3 |
Electronic Materials & Chemicals | 6.4 | 6.2 | 6.8 | 8.3 |
Consolidated | 7.7 | 4.4 | 6.3 | 3.8 |
Segment sales YoY growth (%)
| Segment sales YoY growth (%) | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|
Functional Materials | 3.5 | 1.5 | -8.0 |
Electronic Materials & Chemicals | -10.0 | 10.4 | 14.9 |
Other | -7.4 | -10.9 | 3.0 |
Share of consolidated sales (%)
| Share of consolidated sales (%) | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|
Functional Materials | 49.5 | 53.0 | 51.1 | 45.7 |
Electronic Materials & Chemicals | 48.0 | 44.7 | 46.9 | 52.3 |
Other | 2.5 | 2.4 | 2.0 | 2.0 |
Segment sales (JPY 100M)
| Segment sales (JPY 100M) | FY3/2025 | FY3/2026 | FY3/2027 plan | FY3/2030 plan |
|---|---|---|---|---|
Functional Materials | 285 | 262 | 270 | 260 |
Electronic Materials & Chemicals | 222 | 258 | 264 | 259 |
Medical & Piezoelectric | 39 | 42 | 49 | 60 |
Other | 11 | 12 | 12 | 11 |
Total | 557 | 574 | 595 | 590 |
Segment operating profit (JPY 100M) | FY3/2025 | FY3/2026 | FY3/2027 plan | FY3/2030 plan |
Functional Materials | 15 | -6 | -5 | 4 |
Electronic Materials & Chemicals | 17 | 23 | 22 | 27 |
Medical & Piezoelectric | 0 | 2 | 6 | 12 |
Other | 3 | 3 | 2 | 2 |
Total | 35 | 22 | 25 | 45 |
Revenue by Segment
| Q1 segment data (JPY Mn) | Q1 FY3/2026 | Q1 FY3/2027 |
|---|---|---|
Functional Materials sales | 6,849 | 7,397 |
Electronic Materials & Chemicals sales | 5,610 | 7,218 |
Medical & Piezoelectric sales | 948 | 1,261 |
Other external sales | 272 | 293 |
Consolidated sales | 13,681 | 16,170 |
Functional Materials profit | 274 | 283 |
Electronic Materials & Chemicals profit | 566 | 750 |
Medical & Piezoelectric profit | 54 | 216 |
Other profit | 59 | 57 |
Adjustment | 3 | -1 |
Consolidated operating profit | 957 | 1,306 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric (JPY Mn) | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|---|
Revenue | 46,362 | 54,773 | 52,993 | 55,737 | 57,373 |
Cost of sales | 36,709 | 44,337 | 44,301 | 45,559 | 48,378 |
Gross profit | 9,653 | 10,436 | 8,692 | 10,178 | 8,995 |
SG&A (incl. R&D) | 6,001 | 6,211 | 6,366 | 6,652 | 6,817 |
Operating profit | 3,651 | 4,224 | 2,325 | 3,525 | 2,176 |
Depreciation and goodwill amortisation | 3,455 | 3,419 | 3,202 | 3,199 | 3,941 |
EBITDA (OP + D&A) | 7,106 | 7,643 | 5,527 | 6,724 | 6,117 |
Ordinary profit | 4,156 | 4,717 | 2,802 | 3,747 | 2,672 |
Pre-tax income | 4,093 | 4,270 | 2,685 | 3,514 | -971 |
Net income attributable to owners | 2,845 | 2,986 | 1,866 | 2,422 | -878 |
EPS basic (JPY) | 122.79 | 128.86 | 80.60 | 105.46 | -38.47 |
EPS diluted (JPY) | 122.79 | 128.86 | 80.60 | 105.46 | -38.47 |
Dividend per share (JPY) | 36 | 36 | 38 | 38 | 60 |
Margin (%)
| Margin (%) | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|---|
Gross margin | 20.8 | 19.1 | 16.4 | 18.3 | 15.7 |
Operating margin | 7.9 | 7.7 | 4.4 | 6.3 | 3.8 |
EBITDA margin | 15.3 | 14.0 | 10.4 | 12.1 | 10.7 |
Net margin | 6.1 | 5.5 | 3.5 | 4.3 | -1.5 |
Revenue growth YoY | 20.7 | 18.1 | -3.3 | 5.2 | 2.9 |
Balance Sheet and Margin Analysis (%)
| Metric (JPY Mn) | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|---|
Total assets | 72,128 | 75,717 | 82,709 | 88,345 | 88,558 |
Cash and deposits | 13,060 | 11,661 | 14,308 | 14,092 | 11,273 |
Short-term debt (incl. current portion of LT debt) | — | 3,050 | 3,819 | 4,553 | 6,568 |
Long-term debt | — | 3,805 | 5,710 | 7,981 | 5,809 |
Total interest-bearing debt | 5,005 | 6,855 | 9,529 | 12,534 | 12,377 |
Net debt (negative = net cash) | -8,055 | -4,806 | -4,779 | -1,558 | 1,104 |
Total net assets | 51,263 | 53,658 | 57,764 | 59,400 | 61,491 |
Shareholders' equity (excl. NCI) | 50,896 | 53,219 | 57,286 | 58,834 | 60,972 |
Goodwill and intangibles | 1,628 | 1,526 | 1,410 | 1,149 | 845 |
Investment securities | 10,873 | 9,279 | 13,365 | 12,235 | 17,556 |
Inventories | 14,320 | 19,196 | 18,219 | 18,613 | 18,103 |
Trade receivables (incl. e-notes) | 14,086 | 15,150 | 16,267 | 16,603 | 17,571 |
Working capital (current assets − current liabilities) | — | 32,403 | 34,979 | 33,290 | 31,711 |
Equity ratio (%, company) | 70.6 | 70.3 | 69.3 | 66.6 | 68.9 |
BPS (JPY, company) | — | 2,296.45 | 2,489.06 | 2,578.37 | 2,670.00 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow
| Metric (JPY Mn) | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|---|
Operating cash flow | 4,841 | 581 | 4,978 | 5,056 | 4,541 |
Capital expenditure (PP&E purchases) | 2,473 | 2,687 | 3,617 | 7,334 | 5,710 |
Free cash flow (OCF − capex) | 2,368 | -2,106 | 1,361 | -2,278 | -1,169 |
Dividends paid | 830 | 832 | 832 | 875 | 910 |
Share buybacks | 0 | 0 | 252 | 314 | 0 |
New long-term borrowing | 0 | 4,000 | 5,155 | 6,500 | 2,500 |
Long-term debt repaid | 1,954 | 2,165 | 2,214 | 3,484 | 4,228 |
Change in working capital | -2,029 | -6,082 | -97 | -1,203 | -813 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 |
|---|---|---|---|---|---|
ROE (%, company) | 5.6 | 5.7 | 3.4 | 4.2 | -1.5 |
ROA (%, net income / avg. total assets) | 4.0 | 4.0 | 2.4 | 2.8 | -1.0 |
ROIC (%, OP×(1−30%) / (net assets + debt − cash)) | 5.9 | 6.1 | 3.1 | 4.3 | 2.4 |
Current ratio (x) | — | 3.28 | 3.48 | 3.00 | 2.96 |
Debt / equity (x) | 0.10 | 0.13 | 0.17 | 0.21 | 0.20 |
Net debt / EBITDA (x) | -1.13 | -0.63 | -0.86 | -0.23 | 0.18 |
Interest coverage (OP / interest expense, x) | 107.4 | 81.2 | 27.0 | 27.5 | 15.3 |
Asset turnover (sales / avg. assets, x) | 0.66 | 0.74 | 0.67 | 0.65 | 0.65 |
Days sales outstanding | 110.9 | 101.0 | 112.0 | 108.7 | 111.8 |
Days inventory outstanding | 142.4 | 158.0 | 150.1 | 149.1 | 136.6 |
Days payables outstanding | 68.3 | 54.6 | 50.4 | 49.9 | 45.8 |
Cash conversion cycle (days) | 185.0 | 204.4 | 211.7 | 207.9 | 202.6 |
Proxy Details
| Proxy (JPY Mn) | FY3/2026 |
|---|---|
TAYCA (Thailand) external sales | 11,710 |
TAYCA (Thailand) ordinary profit | 267 |
TAYCA (Thailand) net income | 211 |
TAYCA (Thailand) net assets | 4,124 |
TAYCA (Thailand) total assets | 6,099 |
Region / Channel Details
| Region / channel | Trend and driver (source) |
|---|---|
Japan — pigment TiO2 | Declining: weak architectural-paint demand and import penetration (FY3/2024–FY3/2026 Yuho/Tanshin) |
Overseas — pigment TiO2 exports | Declining: intensified competition from low-priced overseas producers, led by China (FY3/2026 impairment notice) |
Overseas — cosmetic ultrafine particles | Volatile: strong FY3/2023 export recovery, then prolonged destocking in FY3/2025–FY3/2026; ultra-transparent ZnO gaining in the US |
ASEAN — surfactants | Growing: Thai and Vietnamese subsidiaries reported strong household-detergent demand (FY3/2025, Q1 FY3/2027) |
Overseas — piezoelectric | Growing: overseas medical-device customers strong; tariff-avoidance pre-stocking in FY3/2026 |
Global — conductive-polymer agents | Growing: automotive and AI-server capacitor demand (FY3/2025–Q1 FY3/2027) |
Share-price reference (JPY)
| Share-price reference (JPY) | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | Oct-2026 |
|---|---|---|---|---|---|
Price | 1,290 | 1,173 | 1,520 | 1,332 | 2,311 |
Performance Details
| Performance (%) | Value |
|---|---|
52-week price change to 21 Jul 2026 (S&P) | 88.1 |
Change vs FY3/2025 year-end reference | 73.5 |
Change vs FY3/2024 year-end reference | 52.0 |
Change vs FY3/2022 year-end reference | 79.1 |
5-year beta (S&P) | 0.44 |
Valuation Multiples
| Multiple | Tayca | Basis |
|---|---|---|
Market cap (JPY Bn) | 52.4 | 22.66M shares ex-treasury |
Enterprise value (JPY Bn) | 53.7 | Plus debt 11.3, minus cash 10.4, plus NCI 0.5 (30 Jun 2026) |
P/E (FY3/2027E) | 29.3 | Company EPS guide JPY 78.84 |
P/E (FY3/2026) | n/m | Net loss |
EV/EBITDA (FY3/2026) | 8.8 | EBITDA JPY 6.12bn |
EV/EBITDA (FY3/2027 plan) | 8.5 | Plan EBITDA JPY 6.3bn |
EV/Sales (FY3/2026) | 0.94 | — |
P/B | 0.86 | BPS JPY 2,696 (30 Jun 2026) |
Dividend yield (%) | 3.46 | DPS JPY 80 |
Dividend metric
| Dividend metric | FY3/2022 | FY3/2023 | FY3/2024 | FY3/2025 | FY3/2026 | FY3/2027E |
|---|---|---|---|---|---|---|
DPS (JPY) | 36 | 36 | 38 | 38 | 60 | 80 |
Payout ratio (%) | 29.3 | 27.9 | 47.0 | 35.9 | n/m | 101.5 |
Total dividends (JPY Mn, company) | 834 | 834 | 878 | 871 | 1,370 | — |
Buybacks (JPY Mn) | 0 | 0 | 252 | 314 | 0 | 2,500 |
Analyst Conclusions
Management guidance
FY3/2027: sales JPY 59.5bn (+3.7%), OP JPY 2.5bn (+14.9%), NI JPY 1.8bn, DPS JPY 80. H1 raised to OP JPY 1.8bn after a Q1 OP of JPY 1.31bn. FY3/2030: OP JPY 4.5bn, ROE ≥8%, EBITDA JPY 7.3bn, flat sales of JPY 59bn — an explicit mix-and-margin plan rather than a volume plan.
Bull case
-
Q1 run-rate beats guidance: annualising Q1 OP of JPY 1.31bn implies JPY 5bn+, double the full-year guide; even with H2 seasonality, upgrades look likely as conductive-polymer capacity comes online in March 2027.
-
Mix shift toward high-margin niches: Medical & Piezo (17% Q1 margin) and electronics are growing 29–33% while the loss-making TiO2 asset base has already been written down, lowering future depreciation.
-
Capital return of ≈40% of market cap over four years: ≥JPY 20bn of returns versus a JPY 52bn market cap, funded by cross-shareholding sales, supports the shares even with flat earnings.
Bear case
-
Execution track record is poor: two consecutive plans (original MOVING-10 targets, STAGE2) were abandoned; FY3/2030 OP target of JPY 4.5bn is barely above FY3/2023's JPY 4.2bn.
-
Pigment TiO2 can get worse: Chinese oversupply persists; further impairment or restructuring costs are possible, and Functional Materials is still loss-making (plan: −JPY 0.5bn in FY3/2027).
-
Valuation already discounts recovery: 29x forward P/E and a 100%-payout dividend leave no margin for error; Q1 piezo strength may partly reflect tariff pre-buying that could reverse.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Nov 2026 | H1 FY3/2027 results: test of the raised H1 guide; possible full-year upgrade |
| Through Mar 2027 | Buyback execution pace against the JPY 2.5bn authorisation |
| Mar 2027 | Completion of Osaka conductive-polymer expansion |
| FY3/2027 | Cross-shareholding sales (Mitsubishi Corp., Kansai Paint stakes) |
| FY3/2027 | Any restructuring announcement for Okayama pigment TiO2 |
| FY3/2027 | First new-business M&A/VC deployment under the ≥JPY 5bn envelope |
| May 2027 | FY3/2027 results and dividend confirmation; SBTi validation outcome |
| Ongoing | Activist-shareholder engagement; AGM voting on takeover-defence policy |
| Ongoing | Cosmetic-customer inventory normalisation; US tariff developments affecting piezo |
Concluding analyst verdict
Tayca is a company in transition from a century-old commodity-chemicals heritage to a portfolio of defensible micro-niches, and FY3/2026 was the year management finally acknowledged it. The JPY 3.17bn impairment of general-purpose titanium dioxide, the early abandonment of STAGE2 and the adoption of a DOE-3%-floor dividend with ≥JPY 10bn of buybacks represent a genuine break with the passive, cross-shareholding-heavy capital policy that held ROE between 3% and 6% for years. The operating evidence since the reset is encouraging: Q1 FY3/2027 delivered 18% sales growth and 36% operating-profit growth, with conductive-polymer agents and medical piezoelectric materials — businesses that barely registered a decade ago — now carrying the group.
The sceptic's objection is equally grounded in the record. Management has missed or abandoned every quantitative target set since 2020, invested heavily in Functional Materials capacity just before that segment fell into loss, and still runs a 200-day cash conversion cycle. The STAGE3 destination — JPY 4.5bn operating profit and 8% ROE by FY3/2030 — is modest, and the share price, up roughly 75–90% in a year, already prices in much of the capital-return story at nearly 30x guided earnings.
On balance, Tayca now offers a clearer and more investable proposition than at any time in the review period: a sub-1.0x P/B balance-sheet-unlock story with a growing electronics/medical engine and a binding dividend floor. The key swing factors are whether Functional Materials stops losing money, whether cross-shareholdings are actually sold to fund buybacks, and whether electronics growth survives a normalisation of AI-server and tariff-driven demand. Investors should treat the stock as a capital-policy and mix-shift story with real execution risk, and should monitor the November 2026 interim results and buyback pace as the first hard tests of management's new credibility.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title (latest disclosure) | Responsibility | Background | Board tenure |
|---|---|---|---|---|
Shunji Idei (出井俊治) | Representative Director, President & CEO | Internal Audit; Osaka and Okayama Research Institutes | Born 24 Mar 1964 (age 62). Joined Tayca 1986; Head of Okayama Research Institute 2012; Sales Dept. GM 2015; Tokyo Branch GM 2017; Director 2018; President of TFT 2018; Managing EO 2020; Senior Managing EO 2021; CEO since June 2022 | Director since 2018 |
Tamataro Iwasaki (岩崎多摩太郎) | Director, Managing Executive Officer | Environmental Management Planning, Materials, Osaka Plant | Former President of Tayca Warehouse | Director since June 2020 |
Yoshihiro Murata (村田悦宏) | Director, Managing Executive Officer | Sales | Former Tokyo Branch GM | Director since June 2022 |
Hiroshi Nakamura (中村弘) | Director, Senior Executive Officer | General Affairs, HR, Accounting, DX | Investor-relations contact | Director since June 2025 |
Masahiko Tauchi (田内雅彦) | Director, Senior Executive Officer (nominated) | — | Senior Executive Officer | Nominated for election at the 24 June 2026 AGM |
Kosuke Nakatsuka (中務康介) | Director (full-time Audit & Supervisory Committee member) | Audit | Former Managing EO, General Affairs and HR | Director since June 2022; ASC member since June 2025 |
Koji Yamamoto (山本浩二) | Outside Director (ASC) | Audit | Corporate-management experience (per Yuho characterisation of outside directors) | — |
Mamiko Ozaki (尾﨑まみこ) | Outside Director (ASC) | Audit | Academic / technical-research or legal-accounting expertise (Yuho describes the four outside directors collectively) | — |
Takeshi Inoue (井上剛) | Outside Director (ASC) | Audit | As above | — |
Reiko Furushima (古島礼子) | Outside Director (ASC) | Audit | As above | Since June 2025 |
Directors' Remuneration
| Item | Detail |
|---|---|
Board size | 9 directors (4 outside) at 31 March 2026; 10 (4 outside) if the June 2026 AGM slate was approved |
Independence | 44% outside (FY3/2026); 40% after the AGM |
Female directors | 2 of 9 (22.2%) |
Chair / CEO separation | No separate chair disclosed; the President & CEO presides |
Audit & Supervisory Committee | 5 members (1 full-time internal, 4 outside); 11 meetings in FY3/2026 |
Nomination & Compensation Committee | 6 members (2 internal, 4 outside), chaired by the CEO; 4 meetings in FY3/2026 |
Board meetings | 14 in FY3/2026; attendance 100% for all except one retiring outside director |
Other bodies | Management Committee (monthly), Sustainability Committee (CEO-chaired, ≥2/yr), Risk Management Committee, Compliance Committee |
Internal audit | Internal Audit Office (2 staff) |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Jun 2019 | Hirofumi Yamazaki (ex-Mizuho/Dai-Ichi Kangyo Bank) becomes Representative Director | Move to Audit & Supervisory Committee structure |
Jun 2020 | Yamazaki becomes President & CEO; Masao Nagita Chairman | Launch of MOVING-10 |
Jun 2022 | Shunji Idei (career Tayca engineer/salesman) becomes President & CEO; Yamazaki becomes special adviser; Nagita becomes non-executive director | Stated aim: generational renewal and faster response |
Jun 2025 | Akira Miyazaki and Hitoshi Tanaka retire; Hiroshi Nakamura and Reiko Furushima join | Routine rotation |
Jun 2026 | Masahiko Tauchi nominated as Director & Senior EO | Coincides with STAGE3 reorganisation |
Major Shareholders
| Rank | Shareholder | Stake (%) | Shares |
|---|---|---|---|
| 1 | Mitsui & Co., Ltd. | 7.81 | 1,784,000 |
| 2 | The Master Trust Bank of Japan (trust account) | 7.28 | 1,661,000 |
| 3 | Mitsubishi Corporation | 7.14 | 1,630,000 |
| 4 | Yamada Sangyo Co., Ltd. | 6.44 | 1,470,000 |
| 5 | Mizuho Trust & Banking (retirement-benefit trust for Mizuho Bank) | 4.42 | 1,009,000 |
| 6 | Tayca Group Employee Shareholding Association | 4.00 | 914,000 |
| 7 | Chuo-Nittochi Co., Ltd. | 3.04 | 694,000 |
| 8 | Kansai Paint Co., Ltd. | 2.68 | 612,000 |
| 9 | Sumitomo Corporation | 2.19 | 500,000 |
| 10 | Custody Bank of Japan (trust account) | 1.84 | 419,000 |
Competitive Landscape
Competitors by Segment
| Business | Competitor | Positioning vs Tayca |
|---|---|---|
Pigment TiO2 | Ishihara Sangyo Kaisha (TSE 4028) | Japan's largest TiO2 producer and its only chloride-process maker; diversified into agrochemicals; far more profitable |
Pigment TiO2 | Sakai Chemical Industry (TSE 4078) | Domestic TiO2 and functional inorganic chemicals; also cosmetic-grade particles |
Pigment TiO2 | Chinese producers (e.g., LB Group) | Low-cost, large-scale sulphate and chloride capacity; cited by Tayca as the main source of price pressure |
Pigment TiO2 | Tronox, Chemours, Kronos, Venator | Global chloride-process majors; scale and cost leaders outside China |
Cosmetic ultrafine TiO2/ZnO | Sakai Chemical; Ishihara Sangyo | Domestic peers with cosmetic grades |
Cosmetic ultrafine TiO2/ZnO | Croda, BASF, Kobo Products, Sumitomo Osaka Cement | Global ingredient suppliers/dispersers; Tayca competes on particle-control and surface-treatment know-how |
Conductive-polymer materials | Heraeus (Clevios PEDOT), Shin-Etsu Polymer, Nagase ChemteX | Global PEDOT dispersion/material suppliers; Tayca's niche is capacitor-electrolyte oxidant/dopant agents |
Surfactants | Kao, Lion Specialty Chemicals, Sanyo Chemical, and ASEAN LAS producers | Larger integrated surfactant makers; several domestic chemical firms (NOF, Toho Chemical, Daiichi Kogyo Seiyaku) are Tayca customers rather than direct rivals |
Piezoelectric materials | CTS Corporation, CeramTec, PI Ceramic, Fuji Ceramics, Murata, TDK | Ceramic and single-crystal suppliers to ultrasound and sensor OEMs |
Peer Comparison
| Metric | Tayca | Ishihara Sangyo | Sakai Chemical |
|---|---|---|---|
Revenue (JPY Mn) | 57,373 | 154,897 | 81,447 |
Revenue growth (%) | 2.9 | 6.7 | -3.5 |
Operating margin (%) | 3.8 | 12.3 | 7.9 |
ROE (%) | -1.5 | 13.7 | 3.5 |
R&D intensity (%) | 2.0 | — | — |
Equity ratio (%) | 68.9 | 53.7 | — |
Impairment in FY3/2026 (JPY Mn) | 3,170 | — | 2,982 |



